Exhibit 99.1
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
JUNE 30, 2023
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
AS OF JUNE 30, 2023
CONTENTS
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
| | June 30, 2023 | | | December 31, 2022 | |
| | U.S. dollars in thousands | |
Assets | | | | | | |
| | | | | | |
CURRENT ASSETS: | | | | | | |
Cash and cash equivalents | | | 21,410 | | | | 20,024 | |
Short-term deposits | | | 116,632 | | | | 128,363 | |
Trade accounts receivable | | | 16,057 | | | | 11,514 | |
Prepaid expenses and other current assets | | | 4,376 | | | | 4,793 | |
Inventories | | | 19,017 | | | | 23,816 | |
TOTAL CURRENT ASSETS | | | 177,492 | | | | 188,510 | |
| | | | | | | | |
LONG-TERM ASSETS: | | | | | | | | |
Property and equipment, net | | | 3,076 | | | | 2,790 | |
Operating lease right-of-use assets | | | 3,274 | | | | 3,824 | |
Other assets | | | 494 | | | | 535 | |
TOTAL LONG-TERM ASSETS | | | 6,844 | | | | 7,149 | |
TOTAL ASSETS | | | 184,336 | | | | 195,659 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (continued)
| | June 30, 2023 | | | December 31,
2022 | |
| | U.S. dollars in thousands | |
Liabilities and Shareholders’ Equity | | | | | | |
CURRENT LIABILITIES: | | | | | | |
Trade accounts payable | | | 3,896 | | | | 10,651 | |
Accrued compensation | | | 5,198 | | | | 6,206 | |
Current maturities of operating leases liabilities | | | 1,857 | | | | 1,811 | |
Other current liabilities | | | 5,775 | | | | 6,121 | |
TOTAL CURRENT LIABILITIES | | | 16,726 | | | | 24,789 | |
| | | | | | | | |
LONG-TERM LIABILITIES: | | | | | | | | |
Forfeiture Shares, no par value: 1,006,250 shares authorized, issued and outstanding as of June 30, 2023, and December 31, 2022 | | | 222 | | | | 1,751 | |
Non-current operating leases liabilities | | | 989 | | | | 1,624 | |
Other long-term liabilities | | | 122 | | | | 54 | |
TOTAL LONG-TERM LIABILITIES | | | 1,333 | | | | 3,429 | |
TOTAL LIABILITIES | | | 18,059 | | | | 28,218 | |
| | | | | | | | |
COMMITMENTS AND CONTINGENT LIABILITIES (note 5) | | | | | | | | |
| | | | | | | | |
SHAREHOLDERS’ EQUITY: | | | | | | | | |
Ordinary shares, no par value: 700,000,000 shares authorized as of June 30, 2023, and December 31, 2022; 101,843,066, and 98,876,266 (excluding 1,006,250 ordinary shares subject to forfeiture) shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively | | | 49 | | | | 49 | |
Additional paid-in capital | | | 333,862 | | | | 325,067 | |
Accumulated deficit | | | (167,634 | ) | | | (157,675 | ) |
TOTAL SHAREHOLDERS’ EQUITY | | | 166,277 | | | | 167,441 | |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | | | 184,336 | | | | 195,659 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
| | Six months ended June 30 | | | Three months ended June 30 | |
| | 2023 | | | 2022 | | | 2023 | | | 2022 | |
| | U.S. dollars in thousands, except share and per share amounts | |
| | | | | | | | | | | | |
REVENUES | | | 48,055 | | | | 44,101 | | | | 24,175 | | | | 22,481 | |
COST OF REVENUES | | | (17,328 | ) | | | (12,877 | ) | | | (9,241 | ) | | | (6,697 | ) |
GROSS PROFIT | | | 30,727 | | | | 31,224 | | | | 14,934 | | | | 15,784 | |
| | | | | | | | | | | | | | | | |
OPERATING EXPENSES: | | | | | | | | | | | | | | | | |
Research and development expenses | | | (26,121 | ) | | | (29,031 | ) | | | (12,161 | ) | | | (14,904 | ) |
Sales and marketing expenses | | | (9,315 | ) | | | (8,682 | ) | | | (4,255 | ) | | | (4,473 | ) |
General and administrative expenses | | | (7,533 | ) | | | (8,641 | ) | | | (3,701 | ) | | | (4,340 | ) |
TOTAL OPERATING EXPENSES | | | (42,969 | ) | | | (46,354 | ) | | | (20,117 | ) | | | (23,717 | ) |
OPERATING LOSS | | | (12,242 | ) | | | (15,130 | ) | | | (5,183 | ) | | | (7,933 | ) |
Change in fair value of Forfeiture Shares | | | 1,529 | | | | 4,142 | | | | 22 | | | | 1,538 | |
Financial income (expenses), net | | | 792 | | | | (3,675 | ) | | | 601 | | | | (3,560 | ) |
LOSS BEFORE INCOME TAXES | | | (9,921 | ) | | | (14,663 | ) | | | (4,560 | ) | | | (9,955 | ) |
INCOME TAXES | | | (45 | ) | | | (389 | ) | | | (26 | ) | | | (43 | ) |
LOSS AFTER INCOME TAXES | | | (9,966 | ) | | | (15,052 | ) | | | (4,586 | ) | | | (9,998 | ) |
Equity in earnings of an investee | | | 7 | | | | 7 | | | | 4 | | | | 3 | |
NET LOSS | | | (9,959 | ) | | | (15,045 | ) | | | (4,582 | ) | | | (9,995 | ) |
Basic and diluted net loss per ordinary share | | | (0.10 | ) | | | (0.15 | ) | | | (0.05 | ) | | | (0.10 | ) |
Weighted average number of shares used in computing net loss per ordinary share | | | 101,381,153 | | | | 97,296,206 | | | | 101,685,915 | | | | 97,442,359 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
VALENS SEMICONDUCTOR LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (Unaudited)
| | Six months ended June 30, 2023 | |
| | Ordinary shares | | | Additional paid-in | | | Accumulated | | | | |
| | Shares | | | Amount | | | capital | | | deficit | | | Total | |
| | | | | | | | | | | | | | | |
Balance as of January 1, 2023 | | | (*) 98,876,266 | | | | 49 | | | | 325,067 | | | | (157,675 | ) | | | 167,441 | |
Exercise of options and vesting of RSUs | | | 2,966,800 | | | | - | | | | 986 | | | | - | | | | 986 | |
Stock-based compensation | | | - | | | | - | | | | 7,809 | | | | - | | | | 7,809 | |
Net loss for the period | | | - | | | | - | | | | - | | | | (9,959 | ) | | | (9,959 | ) |
Balance as of June 30, 2023 | | | (*) 101,843,066 | | | | 49 | | | | 333,862 | | | | (167,634 | ) | | | 166,277 | |
| | Six months ended June 30, 2022 | |
| | Ordinary shares | | | Additional paid-in | | | Accumulated | | | | |
| | Shares | | | Amount | | | capital | | | deficit | | | Total | |
| | | | | | | | | | | | | | | |
Balance as of January 1, 2022 | | | (*) 97,122,405 | | | | 49 | | | | 312,156 | | | | (130,008 | ) | | | 182,197 | |
Exercise of options | | | 542,264 | | | | - | | | | 150 | | | | - | | | | 150 | |
Stock-based compensation | | | - | | | | - | | | | 5,908 | | | | - | | | | 5,908 | |
Net loss for the period | | | - | | | | - | | | | - | | | | (15,045 | ) | | | (15,045 | ) |
Balance as of June 30, 2022 | | | (*) 97,664,669 | | | | 49 | | | | 318,214 | | | | (145,053 | ) | | | 173,210 | |
| | Three months ended June 30, 2023 | |
| | Ordinary shares | | | Additional paid-in | | | Accumulated | | | | |
| | Shares | | | Amount | | | capital | | | deficit | | | Total | |
| | | | | | | | | | | | | | | |
Balance as of April 1, 2023 | | | (*) 101,465,926 | | | | 49 | | | | 329,817 | | | | (163,052 | ) | | | 166,814 | |
Exercise of options and vesting of RSUs | | | 377,140 | | | | - | | | | 58 | | | | - | | | | 58 | |
Stock-based compensation | | | - | | | | - | | | | 3,987 | | | | - | | | | 3,987 | |
Net loss for the period | | | - | | | | - | | | | - | | | | (4,582 | ) | | | (4,582 | ) |
Balance as of June 30, 2023 | | | (*) 101,843,066 | | | | 49 | | | | 333,862 | | | | (167,634 | ) | | | 166,277 | |
| | Three months ended June 30, 2022 | |
| | Ordinary shares | | | Additional paid-in | | | Accumulated | | | | |
| | Shares | | | Amount | | | capital | | | deficit | | | Total | |
| | | | | | | | | | | | | | | |
Balance as of April 1, 2022 | | | (*) 97,191,467 | | | | 49 | | | | 315,001 | | | | (135,058 | ) | | | 179,992 | |
Exercise of options | | | 473,202 | | | | - | | | | 96 | | | | - | | | | 96 | |
Stock-based compensation | | | - | | | | - | | | | 3,117 | | | | - | | | | 3,117 | |
Net loss for the period | | | - | | | | - | | | | - | | | | (9,995 | ) | | | (9,995 | ) |
Balance as of June 30, 2022 | | | (*) 97,664,669 | | | | 49 | | | | 318,214 | | | | (145,053 | ) | | | 173,210 | |
(*) | Excluding 1,006,250 Forfeiture Shares |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
VALENS SEMICONDUCTOR LTD.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
| | Six months ended June 30 | | | Three months ended June 30 | |
| | 2023 | | | 2022 | | | 2023 | | | 2022 | |
| | U.S. dollars in thousands | |
| | | | | | | | | | | | |
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | | | | |
Net loss for the period | | | (9,959 | ) | | | (15,045 | ) | | | (4,582 | ) | | | (9,995 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | | | | | | | |
Income and expense items not involving cash flows: | | | | | | | | | | | | | | | | |
Depreciation | | | 793 | | | | 667 | | | | 414 | | | | 347 | |
Stock-based compensation | | | 7,809 | | | | 5,908 | | | | 3,987 | | | | 3,117 | |
Exchange rate differences | | | 2,273 | | | | 4,972 | | | | 1,021 | | | | 4,501 | |
Interest on short-term deposits | | | (389 | ) | | | (295 | ) | | | 177 | | | | (132 | ) |
Change in fair value of Forfeiture Shares | | | (1,529 | ) | | | (4,142 | ) | | | (22 | ) | | | (1,538 | ) |
Reduction in the carrying amount of ROU assets | | | 986 | | | | 844 | | | | 522 | | | | 424 | |
Equity in earnings of investee, net of dividend received | | | 7 | | | | 7 | | | | 4 | | | | 3 | |
Changes in operating assets and liabilities: | | | | | | | | | | | | | | | | |
Trade accounts receivable | | | (4,575 | ) | | | (2,952 | ) | | | (3,176 | ) | | | 166 | |
Prepaid expenses and other current assets | | | 403 | | | | 3,763 | | | | 1,042 | | | | 3,245 | |
Inventories | | | 4,799 | | | | (7,996 | ) | | | 4,549 | | | | (4,852 | ) |
Other assets | | | 34 | | | | 183 | | | | (8 | ) | | | 83 | |
Trade accounts payable | | | (6,948 | ) | | | 2,779 | | | | (1,475 | ) | | | 1,691 | |
Accrued compensation | | | (1,008 | ) | | | 329 | | | | 158 | | | | 508 | |
Other current liabilities | | | (216 | ) | | | (366 | ) | | | (1,797 | ) | | | (1,010 | ) |
Change in operating lease liabilities | | | (859 | ) | | | (1,312 | ) | | | (457 | ) | | | (811 | ) |
Other long-term liabilities | | | 68 | | | | 2 | | | | 1 | | | | 2 | |
Net cash provided by (used in) operating activities | | | (8,311 | ) | | | (12,654 | ) | | | 358 | | | | (4,251 | ) |
| | | | | | | | | | | | | | | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | | | | | | | |
Investment in short-term deposits | | | (109,153 | ) | | | (31,340 | ) | | | (68,428 | ) | | | (13,088 | ) |
Maturities of short-term deposits | | | 118,954 | | | | 37,400 | | | | 74,810 | | | | 21,900 | |
Purchase of property and equipment | | | (919 | ) | | | (424 | ) | | | (777 | ) | | | (244 | ) |
Net cash provided by investing activities | | | 8,882 | | | | 5,636 | | | | 5,605 | | | | 8,568 | |
| | | | | | | | | | | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | | | | | | | |
Exercise of stock options | | | 986 | | | | 150 | | | | 58 | | | | 96 | |
Net cash provided by financing activities | | | 986 | | | | 150 | | | | 58 | | | | 96 | |
| | | | | | | | | | | | | | | | |
Effect of exchange rate changes on cash and cash equivalents | | | (171 | ) | | | (3,346 | ) | | | (100 | ) | | | (2,830 | ) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | | | 1,386 | | | | (10,214 | ) | | | 5,921 | | | | 1,583 | |
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD | | | 20,024 | | | | 56,791 | | | | 15,489 | | | | 44,994 | |
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD | | | 21,410 | | | | 46,577 | | | | 21,410 | | | | 46,577 | |
| | | | | | | | | | | | | | | | |
SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION - | | | | | | | | | | | | | | | | |
Cash paid for taxes | | | 252 | | | | 121 | | | | 213 | | | | 65 | |
| | | | | | | | | | | | | | | | |
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | | | | | | | | | | | | | | | | |
Trade accounts payable on account on property and equipment | | | 160 | | | | 73 | | | | 35 | | | | - | |
Operating lease liabilities arising from obtaining operating right-of-use assets | | | 436 | | | | 350 | | | | 152 | | | | 104 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
NOTE 1 - GENERAL:
Valens Semiconductor Ltd. (hereafter “Valens”, and together with its wholly owned subsidiaries, the “Company”), was incorporated in Israel in 2006.
As of September 30, 2021, the Company began trading on the New York Stock Exchange under the Symbol “VLN”.
Please also refer to Note 1(c) in the consolidated financial statement for the year ended December 31, 2022.
Valens is a leading provider of semiconductor products (chips), operates in the Audio-Video and Automotive industries, renowned for its Physical Layer (PHY) technology, enabling resilient high-speed connectivity over simple, low-cost infrastructure. Valens is the inventor of the HDBaseT Technology, which enables the converged delivery of ultra-high-definition digital video and audio, Ethernet, control signals, USB and power through a single cable. In the audio-video space, Valens’ HDBaseT technology enables plug-and-play digital connectivity between ultra-HD video sources and remote displays. In the automotive domain, Valens’ product offering includes both symmetric and asymmetric connectivity technology for high bandwidth transmission of native interfaces over a single low-cost wires and connectors. Valens’ advanced PHY technology for the auto industry provides the safety and resilience required to handle the noisy automotive environment, addressing the needs of Advanced Driver Assistance Systems (ADAS), Automotive Data Solutions (ADS), infotainment, telematics and backbone connectivity.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting.
Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In our opinion, the information contained herein reflects all adjustments necessary for a fair statement of our results of operations, financial position, cash flows, and shareholders’ equity. All such adjustments are of a normal, recurring nature.
The results of operations for the six and three months ended June 30, 2023, shown in these financial statements are not necessarily indicative of the results to be expected for the full year ending December 31, 2023. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2022.
The carrying value of cash and cash equivalents, accounts receivables, deposits and accounts payable (included in the condensed consolidated balance sheets) approximates their fair value because of their generally short maturities.
There have been no material changes in our significant accounting policies as described in our consolidated financial statements for the year ended December 31, 2022, other than as stated below.
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued):
| b. | Accounts receivable, net |
Trade accounts receivable are recorded at the invoiced amount and do not include finance charges. The Company performs ongoing credit evaluation of its customers and generally requires no collateral.
The Company’s accounts receivables accounting policy from January 1, 2023, following the adoption of the new CECL standard:
The Company estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company’s customers to make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable considering historical information, current market conditions and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company’s ongoing evaluation of collectability, customer creditworthiness, historical levels of credit losses, and future expectations.
There were no write-offs of accounts receivable for the six and three months ended June 30, 2023, and 2022, respectively. There are no expected credit losses recorded as of June 30, 2023, and December 31, 2022.
The Company’s accounts receivables accounting policy until December 31, 2022, prior to the adoption of the new CECL standard:
The Company assesses the need for allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments by considering factors such as historical collection experience, credit quality, aging of the accounts receivable balances and current economic conditions that may affect a customer’s ability to pay.
| c. | New Accounting Pronouncements |
Recently Adopted accounting Standards:
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (“ASC 326”): Measurement of Credit Losses on Financial Instruments to introduce a new model for recognizing credit losses on financial instruments based on estimated current expected credit losses, or CECL. Under the new standard, an entity is required to estimate CECL on trade receivables at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The guidance is effective for the Company for annual periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is permitted. The Company adopted ASC 326 on January 1, 2023, and there was no material impact on the Company’s consolidated balance sheet and the consolidated statements of operations upon adoption.
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 3 – INVENTORIES:
| | June 30, 2023 | | | December 31, 2022 | |
| | U.S. dollars in thousands | |
Work in process | | | 8,434 | | | | 9,870 | |
Finished goods | | | 10,583 | | | | 13,946 | |
| | | 19,017 | | | | 23,816 | |
Inventories write-downs amounted to $397 thousand and $0 thousand during the six months ended June 30, 2023, and 2022, respectively. Inventories write-downs amounted to $273 thousand and $0 thousand during the three months ended June 30, 2023, and 2022, respectively. Inventories write-downs are recorded in cost of revenues.
NOTE 4 - COMMITMENTS AND CONTINGENT LIABILITIES:
| a. | Noncancelable Purchase Obligations |
The Company depends upon third party subcontractors for manufacturing of wafers, packaging and final tests. As of June 30, 2023, and December 31, 2022, the total value of open purchase orders for such manufacturing contractors was approximately $10,038 thousand and $19,418 thousand, respectively.
The Company has noncancelable purchase agreements for certain IP embedded in the Company products as well as certain agreement for the license of development tools used by the development team. As of June 30, 2023, and December 31, 2022, the value of non-paid amounts related to such agreements totaled to $1,502 thousand and $2,783 thousand, respectively.
As of June 30, 2023, and to date, the Company is not a party to, or subject to the provisions of any order, writ, injunction, judgment or decree of any court or governmental agency or instrumentality. There is no action, suit, proceeding or investigation by the Company currently pending or that the Company intends to initiate.
NOTE 5 - OTHER CURRENT LIABILITIES:
| | June 30, 2023 | | | December 31, 2022 | |
| | U.S. dollars in thousands | |
| | | | | | |
Accrued vacation | | | 3,387 | | | | 3,203 | |
Taxes payable | | | 37 | | | | 514 | |
Contract liabilities | | | 32 | | | | 175 | |
Accrued expenses- related party | | | 142 | | | | 142 | |
Other Accrued expenses | | | 2,177 | | | | 2,087 | |
| | | 5,775 | | | | 6,121 | |
The amounts of revenues that were included in the contract liabilities’ balance as of December 31, 2022 and December 31, 2021 and were recognized in the period of six months ended June 30, 2023, and June 30, 2022, were $175 and $0 respectively.
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 6 - FORFEITURE SHARES:
| a. | On September 29, 2021 (the “Closing Date”, please refer to note 1c of the financial statements as of December 31, 2022), 1,006,250 Ordinary Shares that PTK sponsor received in respect of its PTK common stock, are subject to forfeiture if certain price targets for the Valens Ordinary Shares are not achieved within a certain period of time (of up to four years), after the Closing Date or if an M&A Transaction (as defined in the Merger Agreement Closing, please refer to note 1c of the financial statements as of December 31, 2022), does not occur at a certain minimum price. |
The Company performed a Monte-Carlo simulation to calculate the fair value of such shares.
The fair value of the Forfeiture Shares was computed using the following key assumptions:
| | June 30, 2023 | | | December 31, 2022 | |
Stock price | | | 2.53 | | | | 5.37 | |
Expected term (years) | | | 1.25-2.25 | | | | 1.75-2.75 | |
Expected volatility | | | 65.32%-68.22 | % | | | 51.37%-53.53 | % |
Risk-free interest rate | | | 4.78%-5.27 | % | | | 4.27%-4.49 | % |
| b. | The table below sets forth a summary of the changes in the fair value of the Forfeiture Shares classified as Level 3: |
| | Six months ended June 30, 2023 | | | Year ended December 31, 2022 | |
| | U.S. dollars in thousands | |
Balance at beginning of period | | | 1,751 | | | | 4,658 | |
Changes in fair value | | | (1,529 | ) | | | (2,907 | ) |
Balance at end of the period | | | 222 | | | | 1,751 | |
NOTE 7 - STOCK-BASED COMPENSATION:
Stock Options
As of June 30, 2023, and December 31, 2022, the number of ordinary shares included in the Company’s option plans totaled to 30,666,212 and 28,383,788, respectively.
1,086,311 out of the outstanding options that have not yet vested as of June 30, 2023, have acceleration mechanisms according to certain terms set forth in the grant agreements primarily in the case of an M&A Transaction which constitutes a Liquidation Event.
As of June 30, 2023, the unrecognized compensation costs related to those unvested stock options are $3,048 thousand, which are expected to be recognized over a weighted-average period of 1.4 years.
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 7 - STOCK-BASED COMPENSATION (continued):
The following is a summary of the status of the Company’s share option plan as of June 30, 2023:
| | Six months ended | |
| | June 30, 2023 | |
| | Number of Options | | | Weighted-Average Exercise price | |
Options outstanding as of December 31, 2022 | | | 13,948,149 | | | $ | 0.85 | |
Granted during the period | | | 212,329 | | | $ | 4.97 | |
Exercised during the period | | | (1,865,217 | ) | | $ | 0.53 | |
Expired during the period | | | (19,876 | ) | | $ | 0.75 | |
Forfeited during the period | | | (28,837 | ) | | $ | 2.85 | |
Options outstanding as of June 30, 2023 | | | 12,246,548 | | | $ | 0.96 | |
Options exercisable as of June 30, 2023 | | | 10,492,188 | | | $ | 0.86 | |
The following table summarizes information about stock options outstanding as of June 30, 2023:
Outstanding as of June 30, 2023 | | | Exercisable as of June 30, 2023 | |
Range of exercise prices | | | Number outstanding | | | Weighted average remaining contractual term | | | Weighted average exercise price | | | Aggregate intrinsic value (U.S. dollars in thousands) | | | Number Exercisable | | | Weighted average remaining contractual term | | | Weighted Average exercise price | | | Aggregate intrinsic value (U.S. dollars in thousands) | |
$ | 0.15-$0.86 | | | | 11,761,752 | | | | 5.25 | | | $ | 0.67 | | | | 20,598 | | | | 10,292,067 | | | | 4.97 | | | $ | 0.77 | | | | 18,144 | |
$ | 1.87 | | | | 4,803 | | | | 7.53 | | | $ | 1.87 | | | | 3 | | | | 3,353 | | | | 7.53 | | | $ | 1.87 | | | | 2 | |
$ | 2.10 | | | | 33,126 | | | | 1.20 | | | $ | 2.10 | | | | 14 | | | | 33,126 | | | | 1.20 | | | $ | 2.10 | | | | 14 | |
$ | 2.40 | | | | 1,474 | | | | 7.00 | | | $ | 2.40 | | | | - | | | | - | | | | - | | | | - | | | | - | |
$ | 4.99 | | | | 200,183 | | | | 6.55 | | | $ | 4.99 | | | | - | | | | 24,906 | | | | 6.55 | | | $ | 4.99 | | | | - | |
$ | 5.36 | | | | 140,000 | | | | 6.00 | | | $ | 5.36 | | | | - | | | | 35,000 | | | | 6.00 | | | $ | 5.36 | | | | - | |
$ | 7.58 | | | | 99,610 | | | | 5.55 | | | $ | 7.58 | | | | - | | | | 99,610 | | | | 5.55 | | | $ | 7.58 | | | | - | |
$ | 9.07 | | | | 5,600 | | | | 5.46 | | | $ | 9.07 | | | | - | | | | 4,126 | | | | 5.46 | | | $ | 9.07 | | | | - | |
The calculated fair value of option grants was estimated using the Black-Scholes option-pricing model with the following assumptions:
| | For the Six months ended on June 30, 2023 | | | For the six months ended on June 30, 2022 | |
Expected term | | | 3-5 | | | | 4-6 | |
Expected volatility | | | 48.35%-63.84 | % | | | 46.73%-47.71 | % |
Expected dividend rate | | | 0 | % | | | 0 | % |
Risk-free rate | | | 3.62%-4.21 | % | | | 1.37%-3.00 | % |
During the six months period ended on June 30, 2023, 212,329 options were granted to related parties (please refer to Note 11 for further information).
As of June 30, 2023, the unrecognized compensation costs related to unvested stock options was $5,985 thousand, which are expected to be recognized over a weighted-average period of 1.55 years.
The weighted-average fair value of the options that were granted during the period ended June 30, 2023 was $2.25 at the grant date.
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 7 - STOCK-BASED COMPENSATION (continued):
The total intrinsic value of options exercised during the period of six months ended June 30, 2023 was $7,965 thousand.
The following table presents the classification of the stock options expenses for the periods indicated:
| | Six months ended June 30 | | | Three months ended June 30 | |
| | 2023 | | | 2022 | | | 2023 | | | 2022 | |
| | U.S. dollars in thousands | |
| | | | | | | | | | | | |
Cost of revenue | | | 96 | | | | 114 | | | | 46 | | | | 60 | |
Research and development | | | 631 | | | | 907 | | | | 309 | | | | 456 | |
Sales and marketing | | | 570 | | | | 655 | | | | 278 | | | | 329 | |
General and administrative | | | 1,350 | | | | 1,404 | | | | 671 | | | | 715 | |
Total stock-based compensation | | | 2,647 | | | | 3,080 | | | | 1,304 | | | | 1,560 | |
Restricted Stock Units
The following is a summary of the status of the Company’s RSU’s as of June 30, 2023, as well as changes during the period of six months ended June 30, 2023:
| | Number of RSUs | | | Weighted-Average Grant Date Fair Value | |
RSUs outstanding at the beginning of the year | | | 3,779,716 | | | $ | 6.08 | |
Granted during the period | | | 3,772,631 | | | $ | 5.17 | |
Vested during the period | | | (1,101,583 | ) | | $ | 6.26 | |
Forfeited during the period | | | (130,311 | ) | | $ | 5.56 | |
Outstanding at the end of the period | | | 6,320,453 | | | $ | 5.52 | |
RSUs exercisable as of June 30, 2023 | | | 5,947,712 | | | $ | 5.52 | |
As of June 30, 2023, the unrecognized compensation cost related to unvested RSUs totaled to approximately $29,410 thousand and is expected to be expensed over a weighted-average recognition period of approximately 3.1 years.
During the six months ended on June 30, 2023, 490,529 RSU’s were granted to several related parties (please refer to Note 11 regarding Related Parties).
The following table presents the classification of RSU’s expenses for the periods indicated:
| | Six months ended June 30 | | | Three months ended June 30 | |
| | 2023 | | | 2022 | | | 2023 | | | 2022 | |
| | U.S. dollars in thousands | |
| | | | | | | | | | | | |
Cost of revenue | | | 288 | | | | 155 | | | | 151 | | | | 84 | |
Research and development | | | 2,779 | | | | 1,467 | | | | 1,462 | | | | 809 | |
Sales and marketing | | | 1,197 | | | | 614 | | | | 613 | | | | 344 | |
General and administrative | | | 898 | | | | 592 | | | | 457 | | | | 320 | |
Total stock-based compensation-RSUs | | | 5,162 | | | | 2,828 | | | | 2,683 | | | | 1,557 | |
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 8 - NET INCOME (LOSS) PER ORDINARY SHARE:
The following table sets forth the computation of basic and diluted net income (loss) per ordinary share for the periods indicated:
| | Six months ended | | | Three months ended | |
| | June 30, 2023 | | | June 30, 2022 | | | June 30, 2023 | | | June 30, 2022 | |
Basic net loss per ordinary share | | | | | | | | | | | | |
Numerator: | | | | | | | | | | | | |
Net loss | | | (9,959 | ) | | | (15,045 | ) | | | (4,582 | ) | | | (9,995 | ) |
| | | | | | | | | | | | | | | | |
Denominator: | | | | | | | | | | | | | | | | |
Weighted average common shares – basic and diluted | | | 101,381,153 | | | | 97, 296,206 | | | | 101,685,915 | | | | 97,442,359 | |
Basic and dilutive net loss per common share | | | (0.10 | ) | | | (0.15 | ) | | | (0.05 | ) | | | (0.10 | ) |
The following weighted-average shares of securities were not included in the computation of diluted net income (loss) per common share as their effect would have been anti-dilutive:
| | Six months ended | | | Three months ended | |
| | June 30, 2023 | | | June 30, 2022 | | | June 30, 2023 | | | June 30, 2022 | |
Options | | | 13,097,348 | | | | 15,378,561 | | | | 12,315,780 | | | | 15,300,870 | |
Restricted Stock Units | | | 5,050,085 | | | | 2,748,135 | | | | 6,486,973 | | | | 3,649,756 | |
Private Warrants | | | 3,330,000 | | | | 3,330,000 | | | | 3,330,000 | | | | 3,330,000 | |
Public Warrants | | | 5,750,000 | | | | 5,750,000 | | | | 5,750,000 | | | | 5,750,000 | |
Forfeiture Shares | | | 1,006,250 | | | | 1,006,250 | | | | 1,006,250 | | | | 1,006,250 | |
NOTE 9 - FINANCIAL INCOME (EXPENSES), NET:
| | Six months ended June 30 | | | Three months ended June 30 | |
| | 2023 | | | 2022 | | | 2023 | | | 2022 | |
| | U.S. dollars in thousands | |
| | | | | | | | | | | | |
Foreign currency exchange differences | | | (2,273 | ) | | | (3,865 | ) | | | (1,021 | ) | | | (3,554 | ) |
Interest income on short-term deposits | | | 3,090 | | | | 404 | | | | 1,630 | | | | 199 | |
Other | | | (25 | ) | | | (214 | ) | | | (8 | ) | | | (205 | ) |
Total financial income (expenses), net | | | 792 | | | | (3,675 | ) | | | 601 | | | | (3,560 | ) |
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER:
| a. | For the purpose of evaluating financial performance and allocating resources, the CODM reviews financial information presented on a consolidated basis accompanied by disaggregated information about revenues, gross profit and operating loss by the two identified reportable segments, to make decisions about resources to be allocated to the segments and assess their performance. Assets information is not provided to the CODM and is not being reviewed. Revenues and cost of goods sold are directly associated with the activities of a specific segment. Direct operating expenses, including general and administrative expenses, associated with the activities of a specific segment are charged to that segment. General and administrative expenses which cannot be attributed directly, are allocated evenly between segments. Other operating expenses are allocated to segments based on headcount ratio. |
| | Six months ended on June 30, 2023 | |
| | Audio-Video | | | Automotive | | | Consolidated | |
| | U.S. dollars in thousands | |
Revenues | | | 31,828 | | | | 16,227 | | | | 48,055 | |
Gross profit | | | 24,734 | | | | 5,993 | | | | 30,727 | |
Research and development expenses | | | 11,094 | | | | 15,027 | | | | 26,121 | |
Sales and marketing expenses | | | 4,009 | | | | 5,306 | | | | 9,315 | |
General and administrative expenses | | | 3,756 | | | | 3,777 | | | | 7,533 | |
Segment operating profit (loss) | | | 5,875 | | | | (18,117 | ) | | | (12,242 | ) |
Change in fair value of Forfeiture Shares | | | | | | | | | | | 1,529 | |
Financial expenses, net | | | | | | | | | | | 792 | |
Loss before taxes on income | | | | | | | | | | | (9,921 | ) |
| | | | | | | | | | | | |
Depreciation expenses | | | 352 | | | | 441 | | | | 793 | |
Stock-based compensation | | | 3,287 | | | | 4,522 | | | | 7,809 | |
| | Six months ended on June 30, 2022 | |
| | Audio-Video | | | Automotive | | | Consolidated | |
| | U.S. dollars in thousands | |
Revenues | | | 35,067 | | | | 9,034 | | | | 44,101 | |
Gross profit | | | 27,881 | | | | 3,343 | | | | 31,224 | |
Research and development expenses | | | 11,392 | | | | 17,639 | | | | 29,031 | |
Sales and marketing expenses | | | 3,695 | | | | 4,987 | | | | 8,682 | |
General and administrative expenses | | | 4,244 | | | | 4,397 | | | | 8,641 | |
Segment operating profit (loss) | | | 8,550 | | | | (23,680 | ) | | | (15,130 | ) |
Change in fair value of Forfeiture Shares | | | | | | | | | | | 4,142 | |
Financial expenses, net | | | | | | | | | | | (3,675 | ) |
Loss before taxes on income | | | | | | | | | | | (14,663 | ) |
| | | | | | | | | | | | |
Depreciation expenses | | | 303 | | | | 364 | | | | 667 | |
Stock-based compensation | | | 2,517 | | | | 3,391 | | | | 5,908 | |
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER (continued):
| | Three months ended on June 30, 2023 | |
| | Audio-Video | | | Automotive | | | Consolidated | |
| | U.S. dollars in thousands | |
Revenues | | | 15,469 | | | | 8,706 | | | | 24,175 | |
Gross profit | | | 11,644 | | | | 3,290 | | | | 14,934 | |
Research and development expenses | | | 4822 | | | | 7,339 | | | | 12,161 | |
Sales and marketing expenses | | | 1,892 | | | | 2,363 | | | | 4,255 | |
General and administrative expenses | | | 1,857 | | | | 1,844 | | | | 3,701 | |
Segment operating profit (loss) | | | 3,072 | | | | (8,255 | ) | | | (5,183 | ) |
Change in fair value of Forfeiture Shares | | | | | | | | | | | 22 | |
Financial expenses, net | | | | | | | | | | | 601 | |
Loss before taxes on income | | | | | | | | | | | (4,560 | ) |
| | | | | | | | | | | | |
Depreciation expenses | | | 173 | | | | 241 | | | | 414 | |
Stock-based compensation | | | 1,678 | | | | 2,309 | | | | 3,987 | |
| | Three months ended on June 30, 2022 | |
| | Audio-Video | | | Automotive | | | Consolidated | |
| | U.S. dollars in thousands | |
Revenues | | | 18,335 | | | | 4,146 | | | | 22,481 | |
Gross profit | | | 14,414 | | | | 1,370 | | | | 15,784 | |
Research and development expenses | | | 5,122 | | | | 9,782 | | | | 14,904 | |
Sales and marketing expenses | | | 1,917 | | | | 2,556 | | | | 4,473 | |
General and administrative expenses | | | 2,081 | | | | 2,259 | | | | 4,340 | |
Segment operating profit (loss) | | | 5,294 | | | | (13,227 | ) | | | (7,933 | ) |
Change in fair value of Forfeiture Shares | | | | | | | | | | | 1,538 | |
Financial expenses, net | | | | | | | | | | | (3,560 | ) |
Loss before taxes on income | | | | | | | | | | | (9,955 | ) |
| | | | | | | | | | | | |
Depreciation expenses | | | 161 | | | | 186 | | | | 347 | |
Stock-based compensation | | | 1,326 | | | | 1,791 | | | | 3,117 | |
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER (continued):
The following table shows revenue by geography, based on the customers’ “bill to” location:
| | Six months ended June 30 | | | Three months ended June 30 | |
| | 2023 | | | 2022 | | | 2023 | | | 2022 | |
| | U.S. dollars in thousands | |
| | | | | | | | | | | | |
Israel | | | 1,266 | | | | 1,279 | | | | 543 | | | | 749 | |
China | | | 4,755 | | | | 5,339 | | | | 2,332 | | | | 2,533 | |
United States | | | 3,441 | | | | 7,238 | | | | 1,981 | | | | 3,681 | |
Hong Kong | | | 4,134 | | | | 7,286 | | | | 2,383 | | | | 3,965 | |
Hungary | | | 13,013 | | | | 6,399 | | | | 6,955 | | | | 2,486 | |
Japan | | | 4,605 | | | | 5,274 | | | | 2,248 | | | | 3,239 | |
Germany | | | 5,637 | | | | 2,807 | | | | 2,989 | | | | 965 | |
Taiwan | | | 4,992 | | | | 4,030 | | | | 1,748 | | | | 2,679 | |
Other | | | 6,212 | | | | 4,449 | | | | 2,996 | | | | 2,184 | |
| | | 48,055 | | | | 44,101 | | | | 24,175 | | | | 22,481 | |
| c. | Supplemental data - Major Customers: |
The following tables summarize the significant customers’ (including distributors) accounts receivable and revenues as a percentage of total accounts receivable and total revenues, respectively:
| | June 30, 2023 | | | December 31, 2022 | |
Accounts Receivable | | % of accounts receivable | |
Customer A | | | 30 | % | | | 10 | % |
Customer B | | | 13 | % | | | 26 | % |
Customer C | | | 0 | % | | | 16 | % |
| | Six months ended June 30, | | | Three months ended June 30, | |
| | 2023 | | | 2022 | | | 2023 | | | 2022 | |
Revenues | | % of revenues | | | % of revenues | |
Customer A | | | 19 | % | | | 10 | % | | | 21 | % | | | 10 | % |
Customer B | | | 11 | % | | | 12 | % | | | 11 | % | | | 15 | % |
Customer D | | | 9 | % | | | 11 | % | | | 9 | % | | | 14 | % |
Customer E | | | 8 | % | | | 6 | % | | | 6 | % | | | 7 | % |
VALENS SEMICONDUCTOR LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (continued)
NOTE 10 - SEGMENT AND REVENUE BY GEOGRAPHY AND BY MAJOR CUSTOMER (continued):
| d. | Long-lived assets by Geography: |
| | June 30, 2023 | | | December 31, 2022 | |
| | U.S. dollars in thousands | |
Domestic (Israel) | | | 5,459 | | | | 5,827 | |
Taiwan | | | 417 | | | | 184 | |
China | | | 206 | | | | 225 | |
USA | | | 154 | | | | 217 | |
Singapore | | | 98 | | | | 124 | |
Other | | | 16 | | | | 37 | |
| | | 6,350 | | | | 6,614 | |
NOTE 11 - RELATED PARTY TRANSACTIONS
During the six months ended June 30, 2023, the Company granted 212,329 stock options, at a weighted average exercise price of $4.97 to several executive officers, and Board of Directors (“Board”) members of the Company. In addition, during the six months ended June 30, 2023 the Company granted 490,529 RSUs to several executive officers and Board members of the Company.
The fair value of the stock options that were granted during the six months ended June 30, 2023 is $438 thousand, which is expected to be recognized over a 1-4 years vesting period, and the fair value of the granted RSUs is $2,354 thousand, which is expected to be recognized over a 1-4-years vesting period.
18
0.05 0.10 0.10 0.15 101381153 101685915 97296206 97442359 97296206 97296206 101381153 101685915 97442359 0.05 0.10 0.10 0.15 false --12-31 Q2 2023-06-30 0001863006 0001863006 2023-01-01 2023-06-30 0001863006 2023-06-30 0001863006 2022-12-31 0001863006 2022-01-01 2022-06-30 0001863006 2023-04-01 2023-06-30 0001863006 2022-04-01 2022-06-30 0001863006 us-gaap:CommonStockMember 2022-12-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001863006 us-gaap:RetainedEarningsMember 2022-12-31 0001863006 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001863006 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001863006 us-gaap:CommonStockMember 2023-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001863006 us-gaap:RetainedEarningsMember 2023-06-30 0001863006 us-gaap:CommonStockMember 2021-12-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001863006 us-gaap:RetainedEarningsMember 2021-12-31 0001863006 2021-12-31 0001863006 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001863006 us-gaap:CommonStockMember 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-06-30 0001863006 2022-06-30 0001863006 us-gaap:CommonStockMember 2023-03-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001863006 us-gaap:RetainedEarningsMember 2023-03-31 0001863006 2023-03-31 0001863006 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001863006 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001863006 us-gaap:CommonStockMember 2022-03-31 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001863006 us-gaap:RetainedEarningsMember 2022-03-31 0001863006 2022-03-31 0001863006 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001863006 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001863006 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2023-06-30 0001863006 us-gaap:CostOfSalesMember 2022-12-31 0001863006 vln:PTKSponsorMember 2023-01-01 2023-06-30 0001863006 srt:MinimumMember 2023-01-01 2023-06-30 0001863006 srt:MaximumMember 2023-01-01 2023-06-30 0001863006 srt:MinimumMember 2022-01-01 2022-12-31 0001863006 srt:MaximumMember 2022-01-01 2022-12-31 0001863006 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001863006 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001863006 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001863006 us-gaap:FairValueInputsLevel3Member 2022-07-01 2022-12-31 0001863006 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001863006 vln:ValensSemiconductorLtdTwoThousandTwentyOneShareIncentivePlanMember 2023-06-30 0001863006 vln:ValensSemiconductorLtdTwoThousandTwentyOneShareIncentivePlanMember 2022-12-31 0001863006 vln:MergerAndAcquisitionTransactionMember us-gaap:EmployeeStockOptionMember 2023-06-30 0001863006 vln:MergerAndAcquisitionTransactionMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember vln:RelatedPartiesMember 2023-01-01 2023-06-30 0001863006 srt:MinimumMember vln:RangeOfExercisePriceOneMember 2023-01-01 2023-06-30 0001863006 srt:MaximumMember vln:RangeOfExercisePriceOneMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceOneMember 2023-06-30 0001863006 vln:RangeOfExercisePriceOneMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceTwoMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceTwoMember 2023-06-30 0001863006 vln:RangeOfExercisePriceThreeMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceThreeMember 2023-06-30 0001863006 vln:RangeOfExercisePriceFourMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePriceFourMember 2023-06-30 0001863006 vln:RangeOfExercisePricesFiveMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesFiveMember 2023-06-30 0001863006 vln:RangeOfExercisePricesSixMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesSixMember 2023-06-30 0001863006 vln:RangeOfExercisePricesSevenMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesSevenMember 2023-06-30 0001863006 vln:RangeOfExercisePricesEightMember 2023-01-01 2023-06-30 0001863006 vln:RangeOfExercisePricesEightMember 2023-06-30 0001863006 srt:MinimumMember 2022-01-01 2022-06-30 0001863006 srt:MaximumMember 2022-01-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001863006 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001863006 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001863006 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-01 2023-06-30 0001863006 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2023-04-01 2023-06-30 0001863006 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2022-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001863006 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-12-31 0001863006 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001863006 vln:TotalStockbasedCompensationRSUsMember 2023-01-01 2023-06-30 0001863006 vln:TotalStockbasedCompensationRSUsMember 2022-01-01 2022-06-30 0001863006 vln:TotalStockbasedCompensationRSUsMember 2023-04-01 2023-06-30 0001863006 vln:TotalStockbasedCompensationRSUsMember 2022-04-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001863006 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001863006 vln:RestrictedStockUnitsMember 2023-01-01 2023-06-30 0001863006 vln:RestrictedStockUnitsMember 2022-01-01 2022-06-30 0001863006 vln:RestrictedStockUnitsMember 2023-04-01 2023-06-30 0001863006 vln:RestrictedStockUnitsMember 2022-04-01 2022-06-30 0001863006 vln:PrivateWarrantMember 2023-01-01 2023-06-30 0001863006 vln:PrivateWarrantMember 2022-01-01 2022-06-30 0001863006 vln:PrivateWarrantMember 2023-04-01 2023-06-30 0001863006 vln:PrivateWarrantMember 2022-04-01 2022-06-30 0001863006 vln:PublicWarrantMember 2023-01-01 2023-06-30 0001863006 vln:PublicWarrantMember 2022-01-01 2022-06-30 0001863006 vln:PublicWarrantMember 2023-04-01 2023-06-30 0001863006 vln:PublicWarrantMember 2022-04-01 2022-06-30 0001863006 vln:ForfeiltureSharesMember 2023-01-01 2023-06-30 0001863006 vln:ForfeiltureSharesMember 2022-01-01 2022-06-30 0001863006 vln:ForfeiltureSharesMember 2023-04-01 2023-06-30 0001863006 vln:ForfeiltureSharesMember 2022-04-01 2022-06-30 0001863006 vln:AudioVideoMember 2023-01-01 2023-06-30 0001863006 vln:AutomotiveMember 2023-01-01 2023-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-06-30 0001863006 vln:AudioVideoMember 2022-01-01 2022-06-30 0001863006 vln:AutomotiveMember 2022-01-01 2022-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2022-01-01 2022-06-30 0001863006 vln:AudioVideoMember 2023-04-01 2023-06-30 0001863006 vln:AutomotiveMember 2023-04-01 2023-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2023-04-01 2023-06-30 0001863006 vln:AudioVideoMember 2022-04-01 2022-06-30 0001863006 vln:AutomotiveMember 2022-04-01 2022-06-30 0001863006 us-gaap:MaterialReconcilingItemsMember 2022-04-01 2022-06-30 0001863006 country:IL 2023-01-01 2023-06-30 0001863006 country:IL 2022-01-01 2022-06-30 0001863006 country:IL 2023-04-01 2023-06-30 0001863006 country:IL 2022-04-01 2022-06-30 0001863006 country:CN 2023-01-01 2023-06-30 0001863006 country:CN 2022-01-01 2022-06-30 0001863006 country:CN 2023-04-01 2023-06-30 0001863006 country:CN 2022-04-01 2022-06-30 0001863006 country:US 2023-01-01 2023-06-30 0001863006 country:US 2022-01-01 2022-06-30 0001863006 country:US 2023-04-01 2023-06-30 0001863006 country:US 2022-04-01 2022-06-30 0001863006 country:HK 2023-01-01 2023-06-30 0001863006 country:HK 2022-01-01 2022-06-30 0001863006 country:HK 2023-04-01 2023-06-30 0001863006 country:HK 2022-04-01 2022-06-30 0001863006 country:HU 2023-01-01 2023-06-30 0001863006 country:HU 2022-01-01 2022-06-30 0001863006 country:HU 2023-04-01 2023-06-30 0001863006 country:HU 2022-04-01 2022-06-30 0001863006 country:JP 2023-01-01 2023-06-30 0001863006 country:JP 2022-01-01 2022-06-30 0001863006 country:JP 2023-04-01 2023-06-30 0001863006 country:JP 2022-04-01 2022-06-30 0001863006 country:DE 2023-01-01 2023-06-30 0001863006 country:DE 2022-01-01 2022-06-30 0001863006 country:DE 2023-04-01 2023-06-30 0001863006 country:DE 2022-04-01 2022-06-30 0001863006 country:TW 2023-01-01 2023-06-30 0001863006 country:TW 2022-01-01 2022-06-30 0001863006 country:TW 2023-04-01 2023-06-30 0001863006 country:TW 2022-04-01 2022-06-30 0001863006 vln:OtherGeographicalAreasMember 2023-01-01 2023-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-01-01 2022-06-30 0001863006 vln:OtherGeographicalAreasMember 2023-04-01 2023-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-04-01 2022-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember 2023-01-01 2023-06-30 0001863006 vln:CustomerAMember us-gaap:AccountsReceivableMember 2022-01-01 2022-12-31 0001863006 vln:CustomerBMember us-gaap:AccountsReceivableMember 2023-01-01 2023-06-30 0001863006 vln:CustomerBMember us-gaap:AccountsReceivableMember 2022-01-01 2022-12-31 0001863006 vln:CustomerCMember us-gaap:AccountsReceivableMember 2023-01-01 2023-06-30 0001863006 vln:CustomerCMember us-gaap:AccountsReceivableMember 2022-01-01 2022-12-31 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerAMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerBMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerDMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2023-04-01 2023-06-30 0001863006 vln:CustomerEMember us-gaap:SalesRevenueNetMember 2022-04-01 2022-06-30 0001863006 country:IL 2023-06-30 0001863006 country:IL 2022-12-31 0001863006 country:TW 2023-06-30 0001863006 country:TW 2022-12-31 0001863006 country:CN 2023-06-30 0001863006 country:CN 2022-12-31 0001863006 country:US 2023-06-30 0001863006 country:US 2022-12-31 0001863006 country:SG 2023-06-30 0001863006 country:SG 2022-12-31 0001863006 vln:OtherGeographicalAreasMember 2023-06-30 0001863006 vln:OtherGeographicalAreasMember 2022-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure